Acertara Acoustic Laboratories, an independent ISO/IEC 17025:2005 accredited medical ultrasound acoustic measurement, testing, and calibration laboratory, and ISO13485:2003 certified probe repair and new product development facility announces it has been awarded United States patent # 8,893,541 for the the Aureon ultrasound probe testing device.
“This patent represents the 16th patent our team has been awarded relative to diagnostic ultrasound system and probe testing devices,” says G. Wayne Moore, President and CEO of Acertara. “Our engineering team first developed the modern ultrasound probe testing paradigm more than 13 years ago when we introduced FirstCall at Sonora Medical Systems. This new patent is the first awarded for our Aureon probe tester.
“Aureon allows the user to visualize the ultrasound energy emanating from the aperture of the probe and detect dead elements and other probe failures in even the most complicated of ultrasound probes including 2D matrix arrays,” he adds. “Aureon represents the first in a family of new probe testing devices designed and developed by our team to empower health technology managers to provide in-hospital quality assurance and functional analysis of ultrasound probes under their care.”
The research and development team at Acertara Acoustic Laboratories has been awarded more than 40 U.S. and international patents ranging from 3D ultrasound products to devices that deliver super-saturated levels of oxygen to myocardial tissue of heart attack patients.
